Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

Neocartilage Implant Phase III Trial

A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)

Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST

Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER